While our cohort did not include confirmed pituitary tumors, the shared hormonal imbalances in PCOS and hyperprolactinemia suggest that similar mechanisms may contribute to elevated galectin-3 levels in these patients. The gene discussed is LGALS3; the disease is pituitary tumor.